RU2005138915A - Сульфонамид замещенные имидазохинолины - Google Patents
Сульфонамид замещенные имидазохинолины Download PDFInfo
- Publication number
- RU2005138915A RU2005138915A RU2005138915/04A RU2005138915A RU2005138915A RU 2005138915 A RU2005138915 A RU 2005138915A RU 2005138915/04 A RU2005138915/04 A RU 2005138915/04A RU 2005138915 A RU2005138915 A RU 2005138915A RU 2005138915 A RU2005138915 A RU 2005138915A
- Authority
- RU
- Russia
- Prior art keywords
- animal
- substance
- effective amount
- salt according
- imidazochinolins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Claims (5)
1. N-{2-[4-амино-2-(этоксиметил)-1H-имидазо-[4,5-c]-хинолин-1-ил]-1,1-диметилэтил}-метансульфонамид или фармацевтически приемлемая соль этого вещества.
2. Фармацевтическая композиция, содержащая терапевтически эффективное количество вещества или его соль по п.1 и фармацевтически приемлемый носитель.
3. Способ индукции биосинтеза цитокинов в организме животного, включающий введение эффективного количества вещества или его соли по п.1 в организм животного.
4. Способ лечения вирусного заболевания у животного, включающий введение эффективного количества вещества или его соли по п.1 в организм животного.
5. Способ лечения онкологического заболевания у животного, включающий введение эффективного количества вещества или его соли по п.1 в организм животного.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48320003P | 2003-06-27 | 2003-06-27 | |
US60/483,200 | 2003-06-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2005138915A true RU2005138915A (ru) | 2006-06-27 |
RU2374246C2 RU2374246C2 (ru) | 2009-11-27 |
Family
ID=33563911
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2005138915/04A RU2374246C2 (ru) | 2003-06-27 | 2004-06-25 | N-{2-[4-АМИНО-2-(ЭТОКСИМЕТИЛ)-1Н-ИМИДАЗО-[4,5-с]-ХИНОЛИН-1-ИЛ]-1,1-ДИМЕТИЛЭТИЛ}-МЕТАНСУЛЬФОНАМИД И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕГО ОСНОВЕ |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1638566A4 (ru) |
JP (1) | JP2007521280A (ru) |
KR (1) | KR20060035637A (ru) |
CN (1) | CN1812789B (ru) |
AR (2) | AR044923A1 (ru) |
AU (1) | AU2004253929A1 (ru) |
BR (1) | BRPI0411916A (ru) |
CA (1) | CA2529322A1 (ru) |
IL (1) | IL172427A0 (ru) |
MX (1) | MXPA06000144A (ru) |
MY (1) | MY157827A (ru) |
NZ (1) | NZ544330A (ru) |
RU (1) | RU2374246C2 (ru) |
TW (2) | TW200511992A (ru) |
WO (2) | WO2005003064A2 (ru) |
ZA (1) | ZA200600769B (ru) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040265351A1 (en) | 2003-04-10 | 2004-12-30 | Miller Richard L. | Methods and compositions for enhancing immune response |
MXPA06001674A (es) | 2003-08-12 | 2006-05-12 | 3M Innovative Properties Co | Compuestos que contienen imidazo hidroxilamina-sustituidos. |
KR101106812B1 (ko) | 2003-08-27 | 2012-01-19 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | 아릴옥시 및 아릴알킬렌옥시 치환된 이미다조퀴놀린 |
EP1660026A4 (en) | 2003-09-05 | 2008-07-16 | 3M Innovative Properties Co | TREATMENT FOR CD5 + B CELL LYMPHOMA |
KR101494056B1 (ko) | 2003-10-03 | 2015-02-16 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | 피라졸로피리딘 및 그의 유사체 |
KR101154101B1 (ko) | 2003-10-03 | 2012-06-11 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | 알콕시 치환된 이미다조퀴놀린 |
US7544697B2 (en) | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
JP2007511527A (ja) | 2003-11-14 | 2007-05-10 | スリーエム イノベイティブ プロパティズ カンパニー | オキシム置換イミダゾ環化合物 |
US8598192B2 (en) | 2003-11-14 | 2013-12-03 | 3M Innovative Properties Company | Hydroxylamine substituted imidazoquinolines |
MXPA06005910A (es) | 2003-11-25 | 2006-08-23 | 3M Innovative Properties Co | Sistemas de anillo imidazo sustituido y metodos. |
EP1689361A4 (en) * | 2003-12-02 | 2009-06-17 | 3M Innovative Properties Co | THERAPEUTIC COMBINATIONS AND PROCESSES WITH IRM COMPOUNDS |
WO2005066170A1 (en) | 2003-12-29 | 2005-07-21 | 3M Innovative Properties Company | Arylalkenyl and arylalkynyl substituted imidazoquinolines |
AU2004312508A1 (en) | 2003-12-30 | 2005-07-21 | 3M Innovative Properties Company | Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides |
AU2005228150A1 (en) | 2004-03-24 | 2005-10-13 | 3M Innovative Properties Company | Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
US8017779B2 (en) | 2004-06-15 | 2011-09-13 | 3M Innovative Properties Company | Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines |
US8541438B2 (en) | 2004-06-18 | 2013-09-24 | 3M Innovative Properties Company | Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
US7897609B2 (en) | 2004-06-18 | 2011-03-01 | 3M Innovative Properties Company | Aryl substituted imidazonaphthyridines |
US7915281B2 (en) | 2004-06-18 | 2011-03-29 | 3M Innovative Properties Company | Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method |
WO2006009826A1 (en) | 2004-06-18 | 2006-01-26 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines |
JP2008526757A (ja) * | 2004-12-30 | 2008-07-24 | スリーエム イノベイティブ プロパティズ カンパニー | 免疫応答調節剤製剤および方法 |
US7943609B2 (en) | 2004-12-30 | 2011-05-17 | 3M Innovative Proprerties Company | Chiral fused [1,2]imidazo[4,5-C] ring compounds |
WO2006083440A2 (en) | 2004-12-30 | 2006-08-10 | 3M Innovative Properties Company | Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds |
CA2597092A1 (en) | 2005-02-04 | 2006-08-10 | Coley Pharmaceutical Group, Inc. | Aqueous gel formulations containing immune reponse modifiers |
JP5122980B2 (ja) | 2005-02-09 | 2013-01-16 | スリーエム イノベイティブ プロパティズ カンパニー | アルキルオキシ置換チアゾロキノリン類およびアルキルオキシ置換チアゾロナフチリデン類 |
CA2597587A1 (en) | 2005-02-11 | 2006-08-17 | Coley Pharmaceutical Group, Inc. | Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods |
AU2006232377A1 (en) | 2005-04-01 | 2006-10-12 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridine-1,4-diamines and analogs thereof |
JP2008538550A (ja) | 2005-04-01 | 2008-10-30 | コーリー ファーマシューティカル グループ,インコーポレイテッド | ウイルス感染および腫瘍性疾患を処置するためのサイトカイン生合成の調節因子としての1−置換ピラゾロ(3,4−c)環状化合物 |
ZA200803029B (en) | 2005-09-09 | 2009-02-25 | Coley Pharm Group Inc | Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods |
CN101300254A (zh) * | 2005-09-09 | 2008-11-05 | 科利制药集团公司 | N-{2-[4-氨基-2-(乙氧基甲基)-1H-咪唑并[4,5-c]喹啉-1-基]-1,1-二甲基乙基}甲磺酰胺的酰胺和氨基甲酸酯衍生物和方法 |
US20090240055A1 (en) * | 2005-09-23 | 2009-09-24 | Krepski Larry R | Method for 1H-Imidazo[4,5-C] Pyridines and Analogs Thereof |
US8951528B2 (en) | 2006-02-22 | 2015-02-10 | 3M Innovative Properties Company | Immune response modifier conjugates |
US7906506B2 (en) | 2006-07-12 | 2011-03-15 | 3M Innovative Properties Company | Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods |
UA105764C2 (ru) * | 2008-03-24 | 2014-06-25 | 4 Сц Аг | Замещенные имидазохинолины |
AU2011292146B2 (en) | 2010-08-17 | 2015-02-05 | Solventum Intellectual Properties Company | Lipidated immune response modifier compound compositions, formulations, and methods |
JP6460789B2 (ja) | 2011-06-03 | 2019-01-30 | スリーエム イノベイティブ プロパティズ カンパニー | ポリエチレングリコールセグメントを有するヘテロ2官能性リンカー及び該リンカーから調製された免疫反応調節複合体 |
WO2012167081A1 (en) | 2011-06-03 | 2012-12-06 | 3M Innovative Properties Company | Hydrazino 1h-imidazoquinolin-4-amines and conjugates made therefrom |
WO2015092592A1 (en) | 2013-12-17 | 2015-06-25 | Pfizer Inc. | Novel 3,4-disubstituted-1h-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7h-pyrrolo[2,3-c]pyridazines as lrrk2 inhibitors |
AU2016322813B2 (en) | 2015-09-14 | 2021-04-01 | Pfizer Inc. | Novel imidazo (4,5-c) quinoline and imidazo (4,5-c)(1,5) naphthyridine derivatives as LRRK2 inhibitors |
JP7011764B2 (ja) | 2016-07-07 | 2022-01-27 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 抗体アジュバント複合体 |
SG10202110112TA (en) | 2017-03-10 | 2021-10-28 | Pfizer | Novel imidazo[4,5-c]quinoline derivatives as lrrk2 inhibitors |
HUE058995T2 (hu) | 2017-09-06 | 2022-10-28 | BioNTech SE | Szubsztituált imidazokinolinok mint a TLR7 agonistái |
CN111511740B (zh) | 2017-12-20 | 2023-05-16 | 3M创新有限公司 | 用作免疫应答调节剂的带有支链连接基团的酰胺取代的咪唑并[4,5-c]喹啉化合物 |
KR20220004634A (ko) | 2019-03-15 | 2022-01-11 | 볼트 바이오테라퓨틱스 인코퍼레이티드 | Her2를 표적으로 하는 면역접합체 |
AU2020407871A1 (en) * | 2019-12-20 | 2022-06-30 | Nammi Therapeutics, Inc. | Formulated and/or co-formulated liposome compositions containing toll-like receptor ("TLR") agonist prodrugs useful in the treatment of cancer and methods thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6331539B1 (en) * | 1999-06-10 | 2001-12-18 | 3M Innovative Properties Company | Sulfonamide and sulfamide substituted imidazoquinolines |
AU2002343728A1 (en) * | 2001-11-16 | 2003-06-10 | 3M Innovative Properties Company | Methods and compositions related to irm compounds and toll-like receptor pathways |
US6677349B1 (en) * | 2001-12-21 | 2004-01-13 | 3M Innovative Properties Company | Sulfonamide and sulfamide substituted imidazoquinolines |
-
2004
- 2004-06-24 MY MYPI20042461A patent/MY157827A/en unknown
- 2004-06-25 NZ NZ544330A patent/NZ544330A/en unknown
- 2004-06-25 CA CA002529322A patent/CA2529322A1/en not_active Abandoned
- 2004-06-25 RU RU2005138915/04A patent/RU2374246C2/ru not_active IP Right Cessation
- 2004-06-25 BR BRPI0411916-9A patent/BRPI0411916A/pt not_active IP Right Cessation
- 2004-06-25 AR ARP040102248A patent/AR044923A1/es unknown
- 2004-06-25 AR ARP040102247A patent/AR044922A1/es unknown
- 2004-06-25 JP JP2006517711A patent/JP2007521280A/ja active Pending
- 2004-06-25 AU AU2004253929A patent/AU2004253929A1/en not_active Abandoned
- 2004-06-25 WO PCT/US2004/020606 patent/WO2005003064A2/en not_active Application Discontinuation
- 2004-06-25 TW TW093118636A patent/TW200511992A/zh unknown
- 2004-06-25 TW TW093118635A patent/TW200514784A/zh unknown
- 2004-06-25 KR KR1020057024904A patent/KR20060035637A/ko not_active Application Discontinuation
- 2004-06-25 WO PCT/US2004/020607 patent/WO2005003065A2/en active Application Filing
- 2004-06-25 EP EP04756208A patent/EP1638566A4/en not_active Withdrawn
- 2004-06-25 CN CN2004800181459A patent/CN1812789B/zh not_active Expired - Fee Related
- 2004-06-25 MX MXPA06000144A patent/MXPA06000144A/es unknown
-
2005
- 2005-12-07 IL IL172427A patent/IL172427A0/en unknown
-
2006
- 2006-01-26 ZA ZA200600769A patent/ZA200600769B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1812789A (zh) | 2006-08-02 |
CN1812789B (zh) | 2010-07-14 |
JP2007521280A (ja) | 2007-08-02 |
AU2004253929A1 (en) | 2005-01-13 |
EP1638566A4 (en) | 2009-03-25 |
CA2529322A1 (en) | 2005-01-13 |
WO2005003065A3 (en) | 2005-03-10 |
RU2374246C2 (ru) | 2009-11-27 |
WO2005003064A2 (en) | 2005-01-13 |
WO2005003065A2 (en) | 2005-01-13 |
AR044922A1 (es) | 2005-10-12 |
ZA200600769B (en) | 2007-05-30 |
AR044923A1 (es) | 2005-10-12 |
MXPA06000144A (es) | 2006-04-07 |
KR20060035637A (ko) | 2006-04-26 |
MY157827A (en) | 2016-07-29 |
TW200514784A (en) | 2005-05-01 |
BRPI0411916A (pt) | 2006-08-15 |
NZ544330A (en) | 2009-06-26 |
IL172427A0 (en) | 2006-04-10 |
WO2005003064A3 (en) | 2005-03-31 |
TW200511992A (en) | 2005-04-01 |
EP1638566A2 (en) | 2006-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2005138915A (ru) | Сульфонамид замещенные имидазохинолины | |
JP2007521280A5 (ru) | ||
WO2007030775A3 (en) | Amide and carbamate derivatives of n-{2-[4-amino-2- (ethoxymethyl)-1h-imidazo[4,5-c]quinolin-1-yl]-1,1-dimethylethyl}methanesulfonamide and methods | |
RU2314307C2 (ru) | СОЕДИНЕНИЕ, ВКЛЮЧАЮЩЕЕ 2-МЕТИЛ-1-(2-МЕТИЛПРОПИЛ)-1Н-ИМИДАЗО[4,5-c][1,5]НАФТИРИДИН-4-АМИН, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕГО ОСНОВЕ И СПОСОБ СТИМУЛЯЦИИ БИОСИНТЕЗА ЦИТОКИНА В ОРГАНИЗМЕ ЖИВОТНЫХ | |
EP1961748A3 (en) | 2-Hydroxy-3-heteroarylindole derivatives as GSK3 inhibitors | |
CY2009002I1 (el) | Χρηση αμινοξικων αντισπασμωδικων για τη θεραπευτικη αγωγη του πονου | |
JP2005513021A5 (ru) | ||
EE200200343A (et) | Asaindooli sisaldav farmatseutiline kompositsioonraviotstarbeliseks kasutamiseks, asaindoolid ningnende kasutamine ravimite valmistamiseks, mis on ette nähtud proteiinikinaasi katalüütilise toime pärssimiseks | |
CA2481848A1 (en) | Active ingredient particles carrying clopidogrel or a salt thereof, their use and method of preparation | |
JP2008526752A5 (ru) | ||
EA200602137A1 (ru) | Гидрогелевые препараты интерферона | |
RU2006131553A (ru) | Комбинация(а) ингибитора топоизомеразы днк и (б) ингибитора iap | |
EA200500632A1 (ru) | Агрегат с повышенной способностью к деформации, содержащий по крайней мере три амфипатических соединения для лучшего проникновения через полунепроницаемые барьеры и для неинвазивного введения лекарственных средств in vivo в особенности через кожу | |
FR2846656B1 (fr) | Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
RU2006118786A (ru) | Твердый препарат | |
RU2003118797A (ru) | Способ количественного определения состава многокомпонентных лекарственных препаратов жаропонижающего, аналгезирующего, противопростудного действия | |
ITRM20030596A1 (it) | Uso di inibitori della pentraxina lunga ptx3, per la preparazione di un medicamento per la prevenzione e cura di patologie che rispondono all'inibizione dell'attivita' biologica di detta ptx3. | |
DE60111459D1 (de) | Zubereitungen zur transdermalen verabreichung hydrophiler substanzen | |
PL356127A1 (en) | Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for the treatment of dry eye | |
FR2842527B1 (fr) | Derives d'acyloxypyrolidine, leur preparation et leur application en therapeutique | |
FR2836143B1 (fr) | Nouveaux derives d'acides amines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
EA200500687A1 (ru) | Применение дистронциевой соли 2-[n,n-ди(карбоксиметил)амино]-3-циано-4-карбоксиметилтиофен-5-карбоновой кислоты при получении лекарственных средств, предназначенных для лечения гастродуоденальной боли | |
EP1714976A4 (en) | AMINO ACID SEQUENCES OF THE ACTIVE PRINCIPLE OF MOSCHUS AND ITS ACETIC ACID SALT AND THE PRODUCTION AND USE THEREOF | |
BR0317292A (pt) | Derivados de amida de ácido antranìlico e seu uso farmacêutico | |
IL152751A0 (en) | Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20110626 |